Ravi Shankar Prasad Singh
About
Ravi Shankar Prasad Singh has authored 47 papers that have received a total of 795 indexed citations.
This includes 14 papers in Molecular Biology, 14 papers in Pharmacology and 10 papers in Oncology. The topics of these papers are Antibiotics Pharmacokinetics and Efficacy (13 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Ravi Shankar Prasad Singh is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Drug Transport and Resistance Mechanisms (5 papers) and collaborates with scholars based in United States, India and Canada. Ravi Shankar Prasad Singh's co-authors include Hartmut Derendorf, Jane Alcorn, Haihong Shi, Jonathan R. Dimmock and Amelia N. Deitchman and has published in prestigious journals such as The Science of The Total Environment, Advanced Drug Delivery Reviews and Antimicrobial Agents and Chemotherapy.
In The Last Decade
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Charuwan Kangkagate Breakdown of academic impact, for papers by Bo-Ji Liu Breakdown of academic impact, for papers by Raffaele Costanzo Breakdown of academic impact, for papers by Tuomo Hjelt Breakdown of academic impact, for papers by Guoqiang Su Breakdown of academic impact, for papers by Vito Calderaro Breakdown of academic impact, for papers by Roberto Antonietti Breakdown of academic impact, for papers by Victor M. H. Borden